2014
Geographical heterogeneity of multidrug-resistant tuberculosis in Georgia, January 2009 to June 2011.
Jenkins HE, Gegia M, Furin J, Kalandadze I, Nanava U, Chakhaia T, Cohen T. Geographical heterogeneity of multidrug-resistant tuberculosis in Georgia, January 2009 to June 2011. Eurosurveillance 2014, 19 PMID: 24679722, PMCID: PMC4090679, DOI: 10.2807/1560-7917.es2014.19.11.20743.Peer-Reviewed Original ResearchConceptsMultidrug-resistant TBMDR-TB risk factorsTB casesRisk factorsMDR-TB incidenceMDR-TB riskMDR-TB transmissionMDR-TB casesMultidrug-resistant tuberculosisTreatment-naïve individualsMDR-TB burdenTuberculosis casesHigh riskTargeted interventionsSurveillance dataGeographical heterogeneityRegression modellingInterventionRiskRural areasCasesTuberculosisIncidencePercentage
2012
Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009.
Gegia M, Cohen T, Kalandadze I, Vashakidze L, Furin J. Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009. The International Journal Of Tuberculosis And Lung Disease 2012, 16: 812-6. PMID: 22507372, PMCID: PMC3786434, DOI: 10.5588/ijtld.11.0637.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntitubercular AgentsChi-Square DistributionDrug Resistance, BacterialDrug Therapy, CombinationEthambutolFemaleGeorgia (Republic)HumansIsoniazidLogistic ModelsMaleMicrobial Sensitivity TestsMiddle AgedMultivariate AnalysisMycobacterium tuberculosisPredictive Value of TestsPyrazinamideRetrospective StudiesRifampinRisk AssessmentRisk FactorsSputumTime FactorsTreatment OutcomeTuberculosisConceptsPulmonary tuberculosisPrevious treatmentOutcomes of patientsPulmonary TB patientsSubset of patientsRetrospective record reviewForms of tuberculosisFirst-line drugsHigh TB ratesDrug-resistant formsLower ratesLow tuberculosisTB patientsTuberculosis patientsOptimal management strategyTreatment regimenRecord reviewTB ratesTreatment successTreatment outcomesCountry of GeorgiaPatientsIsoniazid resistanceTuberculosisDrug resistance